Page last updated: 2024-11-03

risperidone and Renal Insufficiency, Chronic

risperidone has been researched along with Renal Insufficiency, Chronic in 2 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)

Research Excerpts

ExcerptRelevanceReference
" Risperidone, a currently used atypical antipsychotic agent for schizophrenia, is also known to inhibit the activity of D-amino acid oxidase, which degrades certain D-amino acids."8.31Association Between Risperidone Use and Kidney Function Decline in Patients with Schizophrenia: A Retrospective Cohort Study. ( Hara, A; Horikoshi, K; Iwata, Y; Kikuchi, M; Kinoshita, M; Kitajima, S; Minami, T; Mita, M; Miyagawa, T; Nakada, M; Nakade, Y; Nakagawa, S; Ogura, H; Oshima, M; Sakai, N; Shimizu, M; Toyama, T; Wada, T; Yomogida, D; Yuasa, T, 2023)
" Risperidone, a currently used atypical antipsychotic agent for schizophrenia, is also known to inhibit the activity of D-amino acid oxidase, which degrades certain D-amino acids."4.31Association Between Risperidone Use and Kidney Function Decline in Patients with Schizophrenia: A Retrospective Cohort Study. ( Hara, A; Horikoshi, K; Iwata, Y; Kikuchi, M; Kinoshita, M; Kitajima, S; Minami, T; Mita, M; Miyagawa, T; Nakada, M; Nakade, Y; Nakagawa, S; Ogura, H; Oshima, M; Sakai, N; Shimizu, M; Toyama, T; Wada, T; Yomogida, D; Yuasa, T, 2023)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Oshima, M1
Toyama, T1
Nakade, Y1
Yomogida, D1
Yuasa, T1
Horikoshi, K1
Minami, T1
Ogura, H1
Nakagawa, S1
Miyagawa, T1
Kitajima, S1
Hara, A1
Sakai, N1
Shimizu, M1
Mita, M1
Kinoshita, M1
Nakada, M1
Kikuchi, M1
Iwata, Y1
Wada, T1
Blanco-Dominguez, I1
Monsalve, B1
Martínez, LM1
Oteiza, AV1
Bové, M1

Other Studies

2 other studies available for risperidone and Renal Insufficiency, Chronic

ArticleYear
Association Between Risperidone Use and Kidney Function Decline in Patients with Schizophrenia: A Retrospective Cohort Study.
    Clinical therapeutics, 2023, Volume: 45, Issue:9

    Topics: Animals; Antipsychotic Agents; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Mice; Middl

2023
Bilateral anterior ischemic optic neuropathy associated with gastrointestinal hemorrhage and maintenance hemodialysis.
    Journal francais d'ophtalmologie, 2020, Volume: 43, Issue:5

    Topics: Aged; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Hypotension; Hypovolem

2020